/**
 * Copyright 2015 Canada Health Infoway, Inc.
 *
 * Licensed under the Apache License, Version 2.0 (the "License");
 * you may not use this file except in compliance with the License.
 * You may obtain a copy of the License at
 *
 *        http://www.apache.org/licenses/LICENSE-2.0
 *
 * Unless required by applicable law or agreed to in writing, software
 * distributed under the License is distributed on an "AS IS" BASIS,
 * WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
 * See the License for the specific language governing permissions and
 * limitations under the License.
 *
 * Author:        $LastChangedBy: jmis $
 * Last modified: $LastChangedDate: 2015-09-15 10:24:28 -0400 (Tue, 15 Sep 2015) $
 * Revision:      $LastChangedRevision: 9776 $
 */
/* This class was auto-generated by the message builder generator tools. */
namespace Ca.Infoway.Messagebuilder.Model.Pcs_cerx_v01_r04_3.Pharmacy.Pome_mt010040ca {
    using Ca.Infoway.Messagebuilder.Annotation;
    using Ca.Infoway.Messagebuilder.Datatype;
    using Ca.Infoway.Messagebuilder.Datatype.Impl;
    using Ca.Infoway.Messagebuilder.Datatype.Lang;
    using Ca.Infoway.Messagebuilder.Model;


    /**
     * <summary>Business Name: Drug Half-Life</summary>
     * 
     * <p>Impacts contraindication checking for drugs no longer 
     * being taken by patients.</p> <p>Specification of the length 
     * of time a particular drug remains in the body (as 
     * active)</p>
     */
    [Hl7PartTypeMappingAttribute(new string[] {"POME_MT010040CA.HalfLife"})]
    public class DrugHalfLife : MessagePartBean {

        private PQ value;

        public DrugHalfLife() {
            this.value = new PQImpl();
        }
        /**
         * <summary>Business Name: Half-Life Period</summary>
         * 
         * <remarks>Relationship: POME_MT010040CA.HalfLife.value 
         * Conformance/Cardinality: MANDATORY (1) 
         * <p>DrugProduct.HalfLifePeriod</p> <p>Depending on the 
         * half-life, a drug may remain present and active in a 
         * patient's system long after they cease taking it. 
         * Understanding this time period is essential to appropriate 
         * dosing, and also to identifying when to include medications 
         * in drug-drug interaction checking.</p> <p>Different drugs 
         * are absorbed and degraded by the body at different rates. 
         * The half-life indicates the length of time necessary for a 
         * human body to degrade the drug to half its original potency. 
         * The actual time-period will vary from person to person based 
         * on mass, renal function, liver function, route of 
         * administration and other factors</p></remarks>
         */
        [Hl7XmlMappingAttribute(new string[] {"value"})]
        public PhysicalQuantity Value {
            get { return this.value.Value; }
            set { this.value.Value = value; }
        }

    }

}